CTIS2024-515001-26-00
Active, not recruiting
Phase 1
PROPHYLACTIC ANTIBIOTIC TREATMENT IN END-STAGE KIDNEY DISEASE AND CENTRAL VENOUS CATHETER AS HEMODIALYSIS VASCULAR ACCESS - 12020
Region Sjaelland0 sites800 target enrollmentJune 25, 2024
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Blood poisoning in patients with renal failure treated with hemodialysis
- Sponsor
- Region Sjaelland
- Enrollment
- 800
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •End Stage Kidney Disease (ESKD) patients who receive an uncuffed or cuffed CVC for expected chronic HD, regardless of previous ESKD treatment modality (PD or KTX) and hemodialysis access (AV\-fistula or AV\-graft))
Exclusion Criteria
- •Unable to give informed consent, Known intolerance to beta\-lactam antibiotics and clindamycin, Active infection treated with antibiotics, Pregnancy. In women of childbearing age, an approved birth control must be ensured, Patients may be rescreened later i.e. within a time period of one month from start of HD, if exclusion criteria are reversible
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXISSevere infection in patients end stage kidney disease and in hemodialysis with CVC as vascular asscess.MedDRA version: 20.0Level: LLTClassification code 10023420Term: Kidney failure chronicSystem Organ Class: 100000004857Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2020-001033-12-DKiels Eske Bruun800
Active, not recruiting
Phase 1
The early use of Antibiotics in at Risk CHildren with InfluEnza-ARCHIEInfluenza or influenza-like illnessMedDRA version: 16.0 Level: PT Classification code 10022000 Term: Influenza System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2013-002822-21-GBniversity of Oxford650
Recruiting
Phase 3
Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelinesNL-OMON54555HagaZiekenhuis158
Active, not recruiting
Phase 1
Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelinesRecurrent respiratory tract infections in childrenMedDRA version: 25.1Level: LLTClassification code 10038133Term: Recurrent respiratory tract infectionsSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2017-003164-13-NLHaga Teaching Hospital (Juliana Children's Hospital)158
Completed
Not Applicable
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy-C900 Multiple myelomaMultiple myelomaC900PER-011-06EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),